Abstract
Abstract Background Neurofilament light chain (NfL) is a neuron-specific intermediate filament that is released at a consistent low level in normal individuals and increases with age and axonal injuries. NfL is a neurodegeneration biomarker in Alzheimer’s disease (AD), multiple sclerosis, stroke, traumatic brain injury and other neurodegenerative diseases (NDD). Here, we report the analytical performance of plasma NfL using high-sensitivity methodology in a clinical diagnostic laboratory. Methods The analytical performance, encompassing precision, detection limits, interference, and linearity, was evaluated. Plasma NfL levels were measured between July and October 2023 at Neurocode USA in Bellingham, WA, using a single Lumipulse G1200 instrument following CLSI guidelines, particularly for the utilization of the Fujirebio NfL Blood RUO assay as a laboratory-developed test for clinical analysis. A total of 100 healthy control samples, near the age of AD onset, were used to validate the reference ranges. Results The average plasma NfL concentrations varied from ≤ 8.4 to ≤ 37.9 ng/L among healthy individuals aged 20 to 80 years. The Plasma NfL assay exhibits analytical measurements, including a limit of blank (LoB) of 0.75 ng/L, a limit of detection (LoD) of 1.99 ng/ml, and a limit of quantification (LoQ) of 3.96 ng/L. Its linearity ranges from 11.08 to 741.58 ng/L, with intra-laboratory precision ≤ 9% CV. Stability is maintained at 4⁰C for ≤ 72 hours, at room temperature for ≤ 4 hours, at -20⁰C for ≤ 4 weeks, and at -80⁰C for ≤ 7 days, with freeze/thaw cycles tolerated within the specified time frame. Additionally, no interference was observed at the maximum concentrations tested for bilirubin, hemoglobin, and intralipid. Conclusions With a reference range between ≤ 8.4 to ≤ 37.9 ng/L and exceptional analytical performance, the measurement of plasma NfL on a state-of-the-art instrument using CLSI guidelines, can be useful in the diagnosis and monitoring of AD and other NDD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
